NasdaqGS - Delayed Quote USD
NextCure, Inc. (NXTC)
0.4500
+0.0120
+(2.74%)
At close: May 19 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.38 | -0.38 | -1.59 | -1.43 |
| Low Estimate | -0.39 | -0.41 | -1.63 | -1.75 |
| High Estimate | -0.38 | -0.36 | -1.54 | -1.11 |
| Year Ago EPS | -0.55 | -0.41 | -1.99 | -1.59 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.32 | -0.36 | -0.4 |
| EPS Actual | -0.55 | -0.41 | -0.41 | -0.39 |
| Difference | -0.14 | -0.09 | -0.05 | 0.01 |
| Surprise % | -33.33% | -28.12% | -13.89% | 2.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.38 | -0.38 | -1.59 | -1.43 |
| 7 Days Ago | -0.43 | -0.45 | -1.75 | -1.58 |
| 30 Days Ago | -0.43 | -0.45 | -1.75 | -1.58 |
| 60 Days Ago | -0.38 | -0.38 | -1.52 | 0 |
| 90 Days Ago | -0.38 | -0.38 | -1.52 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NXTC | 30.00% | 6.10% | 20.35% | 9.78% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | Needham: Buy to Buy | 8/2/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/31/2024 |
Related Tickers
BOLT Bolt Biotherapeutics, Inc.
0.3277
+11.84%
HLVX HilleVax, Inc.
1.9500
-1.02%
TSBX Turnstone Biologics Corp.
0.3427
+2.24%
PRTC.L PureTech Health plc
128.00
-2.14%
ASMB Assembly Biosciences, Inc.
13.80
+2.83%
VTYX Ventyx Biosciences, Inc.
1.4500
+3.57%
SPRO Spero Therapeutics, Inc.
0.6893
+5.88%
ANTX AN2 Therapeutics, Inc.
1.1900
-1.65%
CRGX CARGO Therapeutics, Inc.
4.0900
-0.73%
KZR Kezar Life Sciences, Inc.
4.0300
-0.98%